During the last session, GoHealth Inc. (NASDAQ:GOCO)’s traded shares were 2.29 million. At the end of the trading day, the stock’s price was $0.69, reflecting an intraday loss of -8.30% or -$0.07. The 52-week high for the GOCO share is $12.12, that puts it down -1656.52 from that peak though still a striking 8.7% gain since the share price plummeted to a 52-week low of $0.63. The company’s market capitalization is $249.42M, and the average trade volume was 3.65 million shares over the past three months.
GoHealth Inc. (GOCO) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.30. GOCO has a Sell rating from 1 analyst(s) out of 8 analysts who have looked at this stock. 5 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 1 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.74.
GoHealth Inc. (NASDAQ:GOCO) trade information
GoHealth Inc. (GOCO) registered a -8.30% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.30% in intraday trading to $0.69 this Thursday, 05/12/22, hitting a weekly high. The stock’s 5-day price performance is -13.51%, and it has moved by -30.61% in 30 days. Based on these gigs, the overall price performance for the year is -94.01%.
GoHealth Inc. (GOCO) estimates and forecasts
Statistics show that GoHealth Inc. has underperformed its competitors in share price, compared to the industry in which it operates. GoHealth Inc. (GOCO) shares have gone down -85.27% during the last six months, with a year-to-date growth rate less than the industry average at -112.84% against -1.60. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 80.50% this quarter and then jump 100.00% in the quarter after that. In the rating firms’ projections, revenue will increase 40.90% compared to the previous financial year.
Revenue for the current quarter is expected to be $630.61 million as predicted by 7 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to $255.51 million by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $445.92 million and $204.18 million respectively. In this case, analysts expect current quarter sales to grow by 41.40% and then jump by 25.10% in the coming quarter.
While earnings are projected to return -908.20% in 2022.
GoHealth Inc. is due to release its next quarterly earnings between March 07 and March 11. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
GoHealth Inc. (NASDAQ:GOCO)’s Major holders
GoHealth Inc. insiders own 1.29% of total outstanding shares while institutional holders control 84.57%, with the float percentage being 85.68%. Centerbridge Partners, L.P. is the largest shareholder of the company, while 184 institutions own stock in it. As of Sep 29, 2021, the company held over 40.68 million shares (or 35.45% of all shares), a total value of $204.64 million in shares.
The next largest institutional holding, with 14.18 million shares, is of Harris Associates L.P.’s that is approximately 12.36% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $71.35 million.
Also, the Mutual Funds coming in first place with the largest holdings of GoHealth Inc. (GOCO) shares are Vanguard Total Stock Market Index Fund and First Tr Exchg Tr AlphaDex Fd-FT Financials AlphaDEX. Data provided on Sep 29, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 2.27 million shares. This amounts to just over 1.98 percent of the company’s overall shares, with a $11.42 million market value. The same data shows that the other fund manager holds slightly less at 1.88 million, or about 1.63% of the stock, which is worth about $6.64 million.